Kappa opioid receptor (KOPr) activation antagonizes many cocaine-related behaviors but adverse side-effects such as sedation, dysphoria, and depression limit their therapeutic use. Recently, salvinorin A (Sal A), a naturally occurring KOPr agonist, has been shown to attenuate cocaineinduced drug seeking in a model of relapse in rats. The present study evaluated the effects of acute Sal A exposure on cocaine-induced hyperactivity and cocaine sensitization in rats. Acute treatment with a dose of Sal A that decreased drug seeking in a previous study (0.3 mg/kg) significantly attenuated the expression of cocaine sensitization. This dose of Sal A failed to affect spontaneous locomotion or to produce a conditioned taste aversion to a novel-tasting saccharin solution. However, Sal A decreased climbing and swimming time and increased time spent immobile in the forced swim test. These findings indicate that Sal A, just like traditional KOPr agonists, attenuates cocaine-induced behavioral sensitization but does not produce the adverse effect of conditioned aversion, suggesting improved potential compliance. However, prodepressive effects were also produced and these effects may limit the therapeutic potential.
Introduction
Kappa opioid receptor (KOPr) agonists have previously been shown to antagonize several cocaine-induced behaviors such as self-administration (Glick et al., 1995; Kuzmin et al., 1997) , reinstatement of drug seeking (Schenk et al., 1999 , Morani et al., 2009 Sun et al., 2010) , hyperactivity (Heidbreder et al., 1993; Vanderschuren et al., 2000; Collins et al., 2001) , and sensitization to conditioned rewarding effects Shippenberg et al., 1996) . These potential antiaddictive properties of this class of compounds have prompted studies aimed at developing KOPr ligands as antiaddiction pharmacotherapies (Mello and Negus, 2000; Prisinzano et al., 2005; Shippenberg et al., 2007; Tomasiewicz et al., 2008) . However, adverse effects produced by traditional KOPr agonists (U504885, U69593, bremazocine, ethylketazocine, Mr2033) such as depression (Mague et al., 2003; Todtenkopf et al., 2004) , aversion (Mucha and Herz, 1985; Shippenberg and Herz, 1986) , sedation (Mello and Negus, 2000; Wadenberg, 2003) , and dysphoria (Walsh et al., 2001) have limited their clinical utility.
Salvia divinorum has been abused as a recreational hallucinogen, particularly among adolescents and young adults (Griffin et al., 2008; Kelly, 2011) . Although salvia use is banned in some countries such as Australia, Italy, Denmark, and Sweden, it is legally available in most parts of the USA and New Zealand (Vorthermes and Roth, 2006; Griffin et al., 2008; Kelly, 2011) . Recent studies show that salvinorin A (Sal A), an active component of the plant S. divinorum, is a potent and selective KOPr agonist (Roth et al., 2002; Yan and Roth, 2004) . Sal A has a rapid onset and short duration of action (Schmidt et al., 2005; Butelman et al., 2007; Hooker et al., 2008 Hooker et al., , 2009 ). It has a unique structure but shares many pharmacological properties with traditional KOPr agonists, including antinociception (John et al., 2006; McCurdy et al., 2006) , discriminative stimulus effects (Willmore-Fordham et al., 2007; Baker et al., 2009) , sedation (Fantagoressi et al., 2005; Zhang et al., 2005) , and depression . Sal A has also been shown to dosedependently and selectively attenuate cocaine-induced drug seeking (Morani et al., 2009) . These findings support the development of novel neoclerodane diterpene KOPr agonists as potential pharmacotherapies for cocaine dependence (Prevatt-Smith and Prisinzano, 2010) . Despite these promising findings, few studies have described other behavioral effects of Sal A.
Previous studies have shown that the conditioned and locomotor behavioral response to cocaine becomes sensitized following either self-administered (Hooks et al., 1994; Phillips and Di Ciano, 1996) or experimenteradministered Heidbreder et al., 1996; Shippenberg et al., 1996) exposures. The mesocorticolimbic dopaminergic system has been implicated in cocaine-produced sensitization, as an increase in extracellular dopamine (DA) levels has been observed following cocaine exposure in the ventral tegmental area (Kalivas and Duffy, 1993b; Reith et al., 1997) and nucleus accumbens (NAc; Di Chiara and Imperato, 1988; Kalivas and Duffy, 1990 , 1993a , 1993b Cadoni et al., 2000) . Development of behavioral sensitization is a paradigm that highlights the ability of cocaine to alter neural circuits underlying its psychomotor effects (Robinson and Berridge, 1993 , 2003 Kalivas et al., 1998; Vanderschuren and Pierce, 2010) . Therefore, finding pharmacological interventions to counter cocaine sensitization in animals could be a useful tool in the identification of anticocaine agents. To the best of our knowledge, no work has been reported on the effect of Sal A on cocaine-induced behavioral sensitization. Therefore, one of the aims of the current study was to investigate the effects of acute systemic Sal A on cocaine locomotor sensitization in rats.
Traditional KOPr agonists have been shown to produce aversion (Mucha and Herz, 1985; Bals-Kubik et al., 1993) and depression (Todtenkopf et al., 2004) in animal models. Sal A produced place aversion and sedation in C57BL/6J mice (Zhang et al., 2005) . In zebrafish and Wistar rats, a low dose of Sal A produced place preference, whereas at a higher dose, Sal A produced place aversion (Braida et al., 2007 (Braida et al., , 2008 . Sal A produces hallucinations in humans (Valdés et al., 1983; Valdés, 1994; Johnson et al., 2011) and nonhuman primates (Butelman et al., 2009) and causes motor suppression in mice (Fantagrossi et al., 2005; Zhang et al., 2005) . However, the aversive and sedative effects of doses of Sal A that selectively attenuate cocaine seeking (0.3 mg/kg) are unknown. Therefore, we evaluated the aversive effect of Sal A using a conditioned taste aversion (CTA) paradigm (Smith et al., 1964; Fenu et al., 2005) and also measured effects on spontaneous locomotor activity (Hooker et al., 2009) . Recent reports on the effects of Sal A on depression have been equivocal, with both prodepressant and antidepressant effects (Braida et al., 2009) reported. The forced swim test (FST) is a widely used behavioral method to measure a depressionlike effect (Porsolt, 1979; Carlezon et al., 2006) that has been used to screen antidepressant drugs in laboratory tests (Detke et al., 1995) . Therefore, we also evaluated the effects of a single injection of Sal A (0.3 mg/kg) on swimming behaviors, using the FST in rats.
Methods

Subjects
Male Sprague-Dawley rats were bred in the vivarium at The School of Psychology, Victoria University. All animals (200-250 g) were housed individually in polycarbonate cages at least 5 days before the experiment at the animal facility under controlled temperature (20 ± 11C) and humidity conditions (55% relative humidity). Lights were maintained at 12 : 12 h, with lights on at 07:00 h. All rats used for the experiments were drug naive and were handled by the experimenter for at least 5 days before the commencement of experiments to avoid handling stress. For cocaine-induced locomotion tests, spontaneous openfield activity, and FST experiments, rats had free access to food and water, except during testing. For the CTA experiments, rats were water deprived for 23 h during the habituation period and for 23 h and 20 min during the saccharin sessions. Food was freely available. All experimental procedures were approved by the Animal Ethics Committee of Victoria University of Wellington.
Apparatus for locomotion tests
Eight open-field chambers (ENV-520; Med Associates, St Albans, Vermont, USA) equipped with two banks of 16 photocells on each wall were used to measure horizontal locomotion. Interruption of three adjacent photobeams, equivalent to the size of the rat, defined one horizontal activity count. Stereotypic counts during the sensitization experiments were determined by measuring repetitive beam breaks obtained from the activity monitoring software (Med Associates). The open-field boxes were interfaced with a microcomputer located adjacent to the boxes. Testing was carried out in the dark in the continuous presence of white noise. For all activity experiments, rats were initially habituated to the locomotion chamber for 30 min. The animals then received drug treatment and were immediately returned to the activity chamber for 60 min. All experiments were carried out between 10:00 and 17:00 h.
Procedure for spontaneous and cocaine-induced locomotion tests
Drug-naive rats were used (n = 14 for the spontaneous open-field test and n = 26 for the cocaine-induced hyperactivity test). For spontaneous activity tests, separate groups of rats were injected on the test day with either vehicle [75% dimethyl sulfoxide (DMSO)] or Sal A [0.3 mg/kg, intraperitoneally (i.p.)] and locomotor activity was measured for 90 min (30 min habituation + 60 min after treatment). For the cocaine-induced activity test, animals were initially habituated in the activity chamber for 30 min. After this, animals were randomly selected and injected with either vehicle (75% DMSO) or Sal A (0.3 mg/kg, i.p.). A total of 5 min after the first injection, rats received either 0.9% saline or cocaine (20 mg/kg, i.p.) and ambulatory counts were measured for 90 min (30 min habituation + 60 min after treatment).
Expression of cocaine sensitization and cocaine-produced stereotypy
A total of 27 drug-naive rats were used for this experiment. Rats were treated with either 0.9% saline or cocaine (20 mg/kg, i.p.) once daily for five consecutive days and were immediately returned to their home cage. On days 6-9, the animals were drug free and remained in the home cage. On day 10, the effects of Sal A on the expression of cocaine sensitization and stereotypy were measured. On the test day, animals were habituated in the activity chamber for 30 min. Rats that were pretreated with either saline or cocaine for five consecutive days were injected with either vehicle (75% DMSO) or Sal A (0.3 mg/kg, i.p.), followed, 5 min later, by cocaine (20 mg/kg, i.p.). Locomotor activity and stereotypic counts were measured for 90 min (30 min pretreatment + 60 min after treatment). The dose of cocaine was selected on the basis of previous reports that showed that cocaine administration (20 mg/kg, i.p.) once daily for five consecutive days produced motor sensitization in rats .
Conditioned taste aversion
CTA was performed on 13 drug-naive rats, following the modified methods of Schenk et al., 1987 and Fenu et al., 2005 . Rats were initially placed on a 23-h water deprivation schedule. The amount of water consumed (ml) during the remaining hour was measured on a daily basis. This process was repeated until the variation in water consumption was less than 2 ml for three consecutive days. The following day, rats were provided with a novel-tasting 0.1% saccharin solution. During the saccharin consumption sessions, rats were presented with the saccharin solution for 40 min and the total amount of saccharin consumed was measured. Animals were matched on consumption of saccharin and placed into treatment groups. These animals were injected with either vehicle (75% DMSO) or Sal A (0.3 mg/kg, i.p.) and returned back to their home cage. On the test day, which was 48 h after the saccharin consumption session, rats were again presented with the novel saccharin solution for 40 min. The amounts of saccharin consumed (ml) on the pairing day and the test day by Sal A-treated rats were compared with the vehicle-treated animals.
Forced swim test
This test was conducted on 12 drug-naive rats following the method described by Porsolt (1979) , with modifications made by Detke et al. (1995) and Carlezon et al. (2006) . On day 1, drug-naive rats were habituated to swimming in an FST chamber (44 cm tall, 20 cm internal diameter) for 15 min. The following day, rats were injected with either vehicle (75% DMSO) or Sal A (0.3 mg/kg), and, 5 min later, the FST was carried out for a period of 5 min. Forced swimming behavior was recorded using a camera connected to an adjacent computer and later scored in 5 s intervals as climbing, swimming, or immobile. The videos were analyzed by an observer who was blind to the experimental procedures.
Drugs
Cocaine HCl (Merck Pharmaceuticals, Palmerston North, New Zealand) was dissolved in 0.9% saline. Sal A isolated by Dr Thomas E. Prisinzano (University of Kansas, Kansas, USA) was suspended in 75% DMSO. All solutions were administered i.p. with the final volume made up to 1 ml/kg. All drug weights refer to salt.
Statistical analysis
Data are expressed as mean ± SEM for locomotion tests, CTA, and FST experiments. Statistical analyses for cocaineinduced locomotion, behavioral sensitization, and stereotypy experiments (for total ambulatory counts) were performed using separate one-way analysis of variance (ANOVA), followed by Tukey post-hoc tests. For timecourse analysis, two-way ANOVAs (treatment Â time) with repeated measures on time were performed, followed by Bonferroni post-hoc tests. Statistical analyses for stereotypic counts were also carried out on the total pooled counts obtained in the 20-min period before and 20 min after cocaine treatment by the Cocaine/Vehicle/Cocaine and Cocaine/Sal A/Cocaine treated groups, using the Mann-Whitney test. Data from the spontaneous locomotion test were analyzed using Student t-tests. For CTA, one-way ANOVA, followed by the Tukey post-hoc test was used. Each behavior in the FST (climbing, swimming, and immobility) was analyzed using the Mann-Whitney test. Statistical significance was set at a P value less than 0.05.
Results
Effect of salvinorin A on spontaneous locomotion and cocaine-induced hyperactivity
No significant difference was observed in spontaneous locomotion between Sal A-pretreated (0.3 mg/kg) and vehicle (75% DMSO)-pretreated rats (Fig. 1) . A single injection of vehicle or Sal A pretreatment had no significant effect on the total locomotor activity produced following a saline (1 ml/kg) injection ( Fig. 2a) . A significant increase in the total locomotor activity was observed in rats pretreated with vehicle or Sal A, followed by an injection of cocaine [20 mg/kg; F(3,22) = 21.52, P < 0.001]. Additional posthoc analysis showed that there was no significant difference in cocaine-produced hyperactivity (total activity) between the Sal A and the vehicle-pretreated group (Fig. 2a ). However, time-course analysis showed a significant increase in locomotor activity in Sal A-treated rats versus vehicletreated controls at 5, 10, and 15 min following cocaine injection [P < 0.05; F(51,396) = 5.05, P < 0.001; Fig. 2b ]. This indicates that acute Sal A (0.3 mg/kg) increased locomotor activity during the first 15 min after cocaine (20 mg/kg) injection without modulating locomotor activity by itself. In addition, post-hoc analysis indicated no significant difference in the locomotion observed during the initial 30-min habituation period (Fig. 2b) .
Effect of salvinorin A on expression of behavioral sensitization
Animals exposed to vehicle, followed by an injection of cocaine on the test day (day 10), showed a significant increase in total locomotion when compared with animals that received saline on days 1-5, indicating the expression of cocaine sensitization [F(3,23) = 3.07, P < 0.05; Fig. 3a ]. Post-hoc tests revealed no significant difference in the total activity of animals exposed to Sal A (0.3 mg/kg) on the test day when they received either saline or cocaine from days 1 to 5 (P > 0.05) (Fig. 3a) . However, further time-course analysis showed a significant reduction in locomotion in Sal A-treated rats versus vehicle-treated groups at 5, 10, 15, and 20 min after cocaine injection [P < 0.05; F(51,441) = 4.0, P < 0.001; Fig. 3b ]. This indicates that acute exposure to Sal A significantly attenuates the expression of cocaine sensitization. Post-hoc analysis showed no significant difference in the locomotion observed during the initial 30-min habituation period for rats that received either saline or cocaine on days 1-5 (Fig. 3b ).
Effect of salvinorin A on cocaine-induced stereotypic counts
Cocaine-induced stereotypy was analyzed by measuring the number of repetitive beam breaks collected during the expression of sensitization experiment. No significant difference in the total number of stereotypic counts produced by cocaine was observed between the Sal Apretreated and vehicle-pretreated controls [F(3,23) = 0.36, NS; Fig. 4a ]. A further time-course analysis showed a significant interaction effect on cocaine-produced stereotypy [F(51,414) = 1.54, P < 0.02; Fig. 4b ], although post-hoc tests revealed no significant difference in the stereotypic counts between Sal A-pretreated and vehiclepretreated cocaine-sensitized animals (Fig. 4b) . A trend toward an increase in the stereotypic counts was noted in Sal A-treated animals in the 20-min period after cocaine injection (Fig. 4b ). Further analysis on pooled stereotypic counts 20 min before and 20 min after cocaine injection between Sal A-treated and vehicle-treated sensitized animals also showed no significant difference (Fig. 4c ).
The effect of salvinorin A on conditioned taste aversion
Statistical analysis indicated no significant difference in the amount of saccharin consumed by vehicle-pretreated and Sal A-pretreated animals [F(3,22) = 2.7, NS; Fig. 5 ]. However, a nonsignificant trend toward an increase in the amount of saccharin consumed by vehicle-treated and Sal A-treated groups on the pairing day versus the test day was noted (Fig. 5 ). Post-hoc tests showed no significant difference in the amount of saccharin consumed (ml) on the test day in rats exposed to Sal A versus vehicle-treated groups (Fig. 5) . Thus, a single injection of Sal A (0.3 mg/kg) paired with a novel-tasting saccharin solution did not produce CTA in rats.
Effect of salvinorin A on the forced swim test
The effect of Sal A (0, 0.3 mg/kg) on climbing, swimming, and immobility behaviors was measured for 5 min on the test day (Fig. 6) . A significant reduction in climbing (P < 0.05) and swimming (P < 0.01) time, and a significant increase in time spent immobile (P < 0.01) were observed for Sal A versus vehicle control rats.
Discussion
An acute treatment with Sal A at 0.3 mg/kg has previously been shown to attenuate cocaine seeking (Morani et al., 2009) . Here, we show that Sal A (0.3 mg/kg) also modulates cocaine-induced locomotor activity in rats.
Sal A suppressed the expression of cocaine sensitization without affecting stereotypic counts or causing taste aversion. However, Sal A induced depressive-like behaviors in the FST. No change in spontaneous open-field activity was observed. In contrast to its attenuating effect on behavioral sensitization, Sal A was shown to increase locomotor activity produced by acute cocaine exposure.
Previous studies have shown that conditioning stimuli can play an important role in the expression of motor sensitized responses in laboratory animals (Post et al., 1981; Beninger and Herz, 1986 ). In the present study, rats that received cocaine or saline injections for five successive days were returned back to their home cage after drug/vehicle exposures, thereby limiting conditioned effects. Therefore, the difference in ambulation on the test day (day 10) was specifically due to the pharmacological effect of the drug on the pretreatment days (days 1-5) (Fig. 3) .
The effects of Sal A on cocaine sensitization might reflect effects on DA neurotransmission. Both the ventral tegmental area and the NAc have been implicated in the initiation and development of cocaine sensitization (Kalivas and Duffy, 1993a; Heidbreder et al., 1996; Shippenberg et al., 1996; Kalivas et al., 1998; Steketee, 2005) , and Sal A modulates DA levels in the dorsal (Zhang et al., 2005; Gehrke et al., 2008) and ventral striatum . The role of this mechanism in the attenuation of cocaine sensitization by Sal A is currently being investigated. Sedation and motor incoordination are two of the commonly documented adverse effects associated with KOPr activation (Mello and Negus, 2000; Walsh et al., 2001; Wadenberg, 2003) . Our results show that Sal A did not suppress open-field activity in drug-naive rats (Fig. 1) , thus suggesting nonsedative effects. This finding also implies that the suppression of cocaine behavioral sensitization by Sal A was not due to nonselective effects (Fig. 3) , as we have previously suggested (Morani et al., 2009) . Sal A (0.3 mg/kg) potentiates cocaine (20 mg/kg)-induced hyperactivity in drug-naive rats (Fig. 2) . However, at high doses, Sal A (2 mg/kg) has been shown to attenuate hyperactivity produced by a low dose of cocaine (10.0 mg/kg) . These effects may be due to previous cocaine exposures, as Sal A (0.3 mg/kg) attenuated behavioral sensitization (current study) and drug seeking in animals with previous cocaine exposures. It is possible that the attenuation of cocaine seeking seen with high doses of Sal A may reflect sedative effects, whereas low doses of Sal A are likely to affect the drugseeking response directly. This idea is supported by other results that also showed that a high dose of Sal A (2.0 mg/kg) increased the intracranial self-stimulation threshold, suppressed sucrose reinforcement, and decreased phasic DA release in NAc (Ebner et al., 2010) , but a lower dose had no effect on any of the measures (Ebner et al., 2010) . Similarly, high doses (1.0, 3.2 mg/kg) produced conditioned place aversion in mice (Zhang et al., 2005) .
The decrease in cocaine-induced behavioral sensitization produced by Sal A may be due to several factors. It could reflect either a decrease in the ability of cocaine to produce horizontal activity or an increase in the ability of cocaine to produce the competing behavior of stereotypy that follows high-dose psychostimulant administration (Post et al., 1987; Ushijima et al., 1995) . Because the dose-effect curve for activity is in the shape of an inverted U, with higher doses producing more intense stereotypy, the present data cannot distinguish between these two possibilities. Detailed studies on cocaine stereotypy and the role of Sal A in modulating this behavior are therefore required to clarify this point. A single exposure to Sal A does not produce taste aversion when paired with a novel-tasting saccharin solution (Fig. 5 ). On close observation, acute Sal A exposure induced a nonsignificant trend toward taste preference. This trend may be due to the low dose of Sal A (0.3 mg/kg) tested in this study. Low doses of Sal A have previously been shown to produce a preference to conditioned behaviors in both zebrafish and rats (Braida et al., 2007; .
Previous reports have shown that Sal A produces both antidepressant (Braida et al., 2007 (Braida et al., , 2008 and prodepressive effects in rats assessed by the FST paradigm . In the current study, acute exposure to Sal A (0.3 mg/kg) produced prodepressive behavior (Fig. 6 ). Because locomotor activity was not altered with this dose of Sal A (Fig. 1) , the effects are probably not attributable to motoric disruption. These results are consistent with the findings of Carlezon et al. (2006) . In contrast to these findings, Braida et al. (2009) showed that acute Sal A (up to 1 mg/kg) exposure produced antidepressant effects in rats using the FST. Animals pretreated with Sal A showed significant reductions in the time spent in both climbing and swimming, as has been reported previously . A decrease in the climbing time has been attributed to the effects of the norepinephrine transporter (NET), whereas modulation of serotonin transporters is implicated in the reduction in swimming time (Detke et al., 1995) . There are no reports on whether KOPrs mediate the modulation of NET. However, previous reports have shown that KOPr activation decreases serotonin levels in brain regions implicated in depressive behaviors (Tao and Auerbach, 2005; Yilmaz et al., 2006) . KOPr activation has also been shown to increase cyclic AMP response element binding protein phosphorylation in the NAc, which is an important marker for depression (Carlezon et al., 1998; Nestler and Carlezon, 2006) . This effect is antagonized by serotonin transporters, NET, or KOPr inhibition (Mague et al., 2003; Chartoff et al., 2009 ). Thus, these effects might reflect KOPr agonist-induced effects on serotonin and/or norepinephrine systems.
The KOPr system has been implicated in the modulation of the hedonic effects produced by cocaine. It has been suggested previously that activation of KOPr may prevent the development and progression of cocaine addiction Effect of a single injection of salvinorin A (Sal A) on the forced swim test (FST) in drug-naive rats (n = 6). On the test day, animals were injected with Sal A and, after 5 min, were subjected to the FST. Data expressed as mean time (s; ± SEM) for climbing, swimming, and immobility behaviors during 5 min of FST. *P < 0.05, **P < 0.01; data for 0.3 mg/kg compared with 0 mg/kg for climbing, swimming, and immobility: Mann-Whitney test. n = 6 per group. i.p., intraperitoneal.
during the initial stages of the addiction cycle (Shippenberg et al., 2001; Chefer et al., 2005; Bruijnzeel, 2009; Mysels and Sullivan, 2009 ). However, adverse effects such as sedation, aversion, and depression have prevented their clinical development (Walsh et al., 2001) . The results from this study establish the role of Sal A in antagonizing cocaine-produced behaviors in the rat with fewer adverse effects. These findings support the development of novel neoclerodane diterpenes as anticocaine agents. However, further work is necessary to identify the mechanism by which Sal A produces its anticocaine and depressive effects.
